Clinical Trial Update: Stereotactic Radiotherapy (SBRT) of Lung Metastasis [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating stereotactic body radiotherapy (SBRT) for treating lung metastases in patients with non-small cell lung cancer and metast…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer
• Pulmonary Metastases

Snippet

Sponsor: University Health Network, Toronto | Conditions: Non-small Cell Lung Cancer, Metastasis From Other Cancers | Phase 2 | Status: RECRUITING